Immune-checkpoint protein VISTA critically regulates the IL-23/IL-17 inflammatory axis
Abstract V-domain Immunoglobulin Suppressor of T cell Activation (VISTA) is an inhibitory immune-checkpoint molecule that suppresses CD4+ and CD8+ T cell activation when expressed on antigen-presenting cells. Vsir −/− mice developed loss of peripheral tolerance and multi-organ chronic inflammatory p...
Guardado en:
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1b0571cb47a145ed901429ee57439f62 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:1b0571cb47a145ed901429ee57439f62 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:1b0571cb47a145ed901429ee57439f622021-12-02T11:52:59ZImmune-checkpoint protein VISTA critically regulates the IL-23/IL-17 inflammatory axis10.1038/s41598-017-01411-12045-2322https://doaj.org/article/1b0571cb47a145ed901429ee57439f622017-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-01411-1https://doaj.org/toc/2045-2322Abstract V-domain Immunoglobulin Suppressor of T cell Activation (VISTA) is an inhibitory immune-checkpoint molecule that suppresses CD4+ and CD8+ T cell activation when expressed on antigen-presenting cells. Vsir −/− mice developed loss of peripheral tolerance and multi-organ chronic inflammatory phenotypes. Vsir −/− CD4+ and CD8+ T cells were hyper-responsive towards self- and foreign antigens. Whether or not VISTA regulates innate immunity is unknown. Using a murine model of psoriasis induced by TLR7 agonist imiquimod (IMQ), we show that VISTA deficiency exacerbated psoriasiform inflammation. Enhanced TLR7 signaling in Vsir −/− dendritic cells (DCs) led to the hyper-activation of Erk1/2 and Jnk1/2, and augmented the production of IL-23. IL-23, in turn, promoted the expression of IL-17A in both TCRγδ+ T cells and CD4+ Th17 cells. Furthermore, VISTA regulates the peripheral homeostasis of CD27− γδ T cells and their activation upon TCR-mediated or cytokine-mediated stimulation. IL-17A-producing CD27− γδ T cells were expanded in the Vsir −/− mice and amplified the inflammatory cascade. In conclusion, this study has demonstrated that VISTA critically regulates the inflammatory responses mediated by DCs and IL-17-producing TCRγδ+ and CD4+ Th17 T cells following TLR7 stimulation. Our finding provides a rationale for therapeutically enhancing VISTA-mediated pathways to benefit the treatment of autoimmune and inflammatory disorders.Na LiWenwen XuYing YuanNatarajan AyithanYasutomo ImaiXuesong WuHalli MillerMichael OlsonYunfeng FengYina H. HuangMary Jo TurkSamuel T. HwangSubramaniam MalarkannanLi WangNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-11 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Na Li Wenwen Xu Ying Yuan Natarajan Ayithan Yasutomo Imai Xuesong Wu Halli Miller Michael Olson Yunfeng Feng Yina H. Huang Mary Jo Turk Samuel T. Hwang Subramaniam Malarkannan Li Wang Immune-checkpoint protein VISTA critically regulates the IL-23/IL-17 inflammatory axis |
description |
Abstract V-domain Immunoglobulin Suppressor of T cell Activation (VISTA) is an inhibitory immune-checkpoint molecule that suppresses CD4+ and CD8+ T cell activation when expressed on antigen-presenting cells. Vsir −/− mice developed loss of peripheral tolerance and multi-organ chronic inflammatory phenotypes. Vsir −/− CD4+ and CD8+ T cells were hyper-responsive towards self- and foreign antigens. Whether or not VISTA regulates innate immunity is unknown. Using a murine model of psoriasis induced by TLR7 agonist imiquimod (IMQ), we show that VISTA deficiency exacerbated psoriasiform inflammation. Enhanced TLR7 signaling in Vsir −/− dendritic cells (DCs) led to the hyper-activation of Erk1/2 and Jnk1/2, and augmented the production of IL-23. IL-23, in turn, promoted the expression of IL-17A in both TCRγδ+ T cells and CD4+ Th17 cells. Furthermore, VISTA regulates the peripheral homeostasis of CD27− γδ T cells and their activation upon TCR-mediated or cytokine-mediated stimulation. IL-17A-producing CD27− γδ T cells were expanded in the Vsir −/− mice and amplified the inflammatory cascade. In conclusion, this study has demonstrated that VISTA critically regulates the inflammatory responses mediated by DCs and IL-17-producing TCRγδ+ and CD4+ Th17 T cells following TLR7 stimulation. Our finding provides a rationale for therapeutically enhancing VISTA-mediated pathways to benefit the treatment of autoimmune and inflammatory disorders. |
format |
article |
author |
Na Li Wenwen Xu Ying Yuan Natarajan Ayithan Yasutomo Imai Xuesong Wu Halli Miller Michael Olson Yunfeng Feng Yina H. Huang Mary Jo Turk Samuel T. Hwang Subramaniam Malarkannan Li Wang |
author_facet |
Na Li Wenwen Xu Ying Yuan Natarajan Ayithan Yasutomo Imai Xuesong Wu Halli Miller Michael Olson Yunfeng Feng Yina H. Huang Mary Jo Turk Samuel T. Hwang Subramaniam Malarkannan Li Wang |
author_sort |
Na Li |
title |
Immune-checkpoint protein VISTA critically regulates the IL-23/IL-17 inflammatory axis |
title_short |
Immune-checkpoint protein VISTA critically regulates the IL-23/IL-17 inflammatory axis |
title_full |
Immune-checkpoint protein VISTA critically regulates the IL-23/IL-17 inflammatory axis |
title_fullStr |
Immune-checkpoint protein VISTA critically regulates the IL-23/IL-17 inflammatory axis |
title_full_unstemmed |
Immune-checkpoint protein VISTA critically regulates the IL-23/IL-17 inflammatory axis |
title_sort |
immune-checkpoint protein vista critically regulates the il-23/il-17 inflammatory axis |
publisher |
Nature Portfolio |
publishDate |
2017 |
url |
https://doaj.org/article/1b0571cb47a145ed901429ee57439f62 |
work_keys_str_mv |
AT nali immunecheckpointproteinvistacriticallyregulatestheil23il17inflammatoryaxis AT wenwenxu immunecheckpointproteinvistacriticallyregulatestheil23il17inflammatoryaxis AT yingyuan immunecheckpointproteinvistacriticallyregulatestheil23il17inflammatoryaxis AT natarajanayithan immunecheckpointproteinvistacriticallyregulatestheil23il17inflammatoryaxis AT yasutomoimai immunecheckpointproteinvistacriticallyregulatestheil23il17inflammatoryaxis AT xuesongwu immunecheckpointproteinvistacriticallyregulatestheil23il17inflammatoryaxis AT hallimiller immunecheckpointproteinvistacriticallyregulatestheil23il17inflammatoryaxis AT michaelolson immunecheckpointproteinvistacriticallyregulatestheil23il17inflammatoryaxis AT yunfengfeng immunecheckpointproteinvistacriticallyregulatestheil23il17inflammatoryaxis AT yinahhuang immunecheckpointproteinvistacriticallyregulatestheil23il17inflammatoryaxis AT maryjoturk immunecheckpointproteinvistacriticallyregulatestheil23il17inflammatoryaxis AT samuelthwang immunecheckpointproteinvistacriticallyregulatestheil23il17inflammatoryaxis AT subramaniammalarkannan immunecheckpointproteinvistacriticallyregulatestheil23il17inflammatoryaxis AT liwang immunecheckpointproteinvistacriticallyregulatestheil23il17inflammatoryaxis |
_version_ |
1718394910382489600 |